CG Oncology Director James Mulay Liquidates Entire Holdings Under Pre-Arranged Trading Plan
CG Oncology, Inc. (NASDAQ:CGON) Director James Mulay executed a series of stock transactions on June 15, 2026, resulting in the sale of all his direct holdings in the company. The transactions involved the exercise of previously granted stock options followed by the immediate sale of the acquired shares. This activity occurred under a Rule 10b5-1 t…